TOI
Income statement / Annual
Last year (2023), The Oncology Institute, Inc.'s total revenue was $324.24 M,
an increase of 28.42% from the previous year.
In 2023, The Oncology Institute, Inc.'s net income was -$83.07 M.
See The Oncology Institute, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$324.24 M
|
$252.48 M
|
$203.00 M
|
$187.51 M
|
$155.41 M
|
$113.16 M
|
| Cost of Revenue |
$264.67 M |
$200.39 M |
$162.16 M |
$150.64 M |
$125.46 M |
$86.88 M |
| Gross Profit |
$59.57 M |
$52.09 M |
$40.85 M |
$36.88 M |
$29.94 M |
$26.28 M |
| Gross Profit Ratio |
0.18 |
0.21 |
0.2 |
0.2 |
0.19 |
0.23 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$309,169.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$41.59 M
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$113.85 M
|
$119.69 M
|
$83.37 M
|
$41.90 M
|
$29.64 M
|
$20.39 M
|
| Other Expenses |
$22.74 M |
$4.41 M |
$3.34 M |
$3.18 M |
$2.94 M |
$1.10 M |
| Operating Expenses |
$136.59 M |
$124.10 M |
$86.71 M |
$45.07 M |
$32.59 M |
$21.49 M |
| Cost And Expenses |
$401.26 M |
$324.49 M |
$248.86 M |
$195.71 M |
$158.05 M |
$108.37 M |
| Interest Income |
$0.00 |
$4.08 M |
$320,000.00 |
$254,149.00 |
$3,375.00 |
$0.00 |
| Interest Expense |
$6.78 M |
$4.08 M |
$320,000.00 |
$347,060.00 |
$3,375.00 |
$1,592.00 |
| Depreciation &
Amortization |
$5.87 M
|
$4.41 M
|
$3.34 M
|
$3.18 M
|
$2.94 M
|
$1.10 M
|
| EBITDA |
-$70.45 M
|
$8.40 M
|
-$7.94 M
|
-$11.29 M
|
$307,109.00
|
$9.08 M
|
| EBITDA Ratio |
-0.22 |
-0.27 |
-0.2 |
-0.06 |
0 |
0.05 |
| Operating Income Ratio
|
-0.24
|
-0.29
|
-0.23
|
-0.04
|
-0.02
|
0.04
|
| Total Other
Income/Expenses Net |
-$6.09 M
|
$81.86 M
|
$34.26 M
|
-$6.62 M
|
$6,625.00
|
$71,175.00
|
| Income Before Tax |
-$83.10 M |
$1.90 M |
-$11.60 M |
-$14.81 M |
-$2.64 M |
$4.86 M |
| Income Before Tax Ratio
|
-0.26
|
0.01
|
-0.06
|
-0.08
|
-0.02
|
0.04
|
| Income Tax Expense |
-$36,000.00 |
$247,000.00 |
-$671,000.00 |
-$492,823.00 |
$1.38 M |
$912,745.00 |
| Net Income |
-$83.07 M |
$1.66 M |
-$10.93 M |
-$14.32 M |
-$4.02 M |
$3.95 M |
| Net Income Ratio |
-0.26 |
0.01 |
-0.05 |
-0.08 |
-0.03 |
0.03 |
| EPS |
-0.92 |
0.0228 |
-0.16 |
-0.24 |
-0.0624 |
0.14 |
| EPS Diluted |
-0.92 |
0.0206 |
-0.16 |
-0.24 |
-0.0624 |
0.14 |
| Weighted Average Shares
Out |
$73.75 M
|
$72.79 M
|
$66.23 M
|
$59.12 M
|
$64.45 M
|
$28.75 M
|
| Weighted Average Shares
Out Diluted |
$73.75 M
|
$80.61 M
|
$66.23 M
|
$59.12 M
|
$64.45 M
|
$28.75 M
|
| Link |
|
|
|
|
|
|
